Citation Impact
Citing Papers
Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival
2008
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
2002
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
2004
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients
2003
Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial
2005
The type 2 human somatostatin receptor as a platform for reporter gene imaging
2002
Acromegaly
2006 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Molecular imaging with copper-64
2004
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
The Future of Cancer Imaging
2002
Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
2007
“Click”-Cyclized 68Ga-Labeled Peptides for Molecular Imaging and Therapy: Synthesis and Preliminary In Vitro and In Vivo Evaluation in a Melanoma Model System
2012
Taking advantage of luminescent lanthanide ions
2005 Standout
Cushing's syndrome
2015 Standout
A complete substitutional analysis of VIP for better tumor imaging properties
2002
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
2011
Phaeochromocytoma
2005 Standout
Bioinorganic aspects of angiogenesis
2010
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Ligand liposomes and boron neutron capture therapy
2003
Synthesis of [18F]RGD-K5 by catalyzed [3+2] cycloaddition for imaging integrin αvβ3 expression in vivo
2013 StandoutNobel
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Clinical applications of newer radionuclide therapies
2006
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies
2008
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study
2006
Synthesis and characterisation of highly emissive and kinetically stable lanthanide complexes suitable for usage ‘in cellulo’
2005
Regulation of cancer cell metabolism
2011 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Optical imaging of metastatic tumors using a folate-targeted fluorescent probe
2003
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
2003
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
2006
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Conformationally Homogeneous Heterocyclic Pseudotetrapeptides as Three‐Dimensional Scaffolds for Rational Drug Design: Receptor‐Selective Somatostatin Analogues
2009
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
2006
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Peptide therapeutics: current status and future directions
2014 Standout
Pyrene-sensitised near-IR luminescence from ytterbium and neodymium complexes
2004
Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation
2004
The Spot Technique: Synthesis and Screening of Peptide Macroarrays on Cellulose Membranes
2008 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer
2007
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Radiolabeled Cyclic RGD Peptides as Integrin αvβ3-Targeted Radiotracers: Maximizing Binding Affinity via Bivalency
2009
Octreotide-Targeted Liposomes Loaded with CPT-11 Enhanced Cytotoxicity for the Treatment of Medullary Thyroid Carcinoma
2010
First-row transition-metal complexes of mixed ‘pendant-arm’ derivatives of 1,4,7-triazacyclononane containing phenolate and carboxylate functional groups
1996
Improved 18F Labeling of Peptides with a Fluoride-Aluminum-Chelate Complex
2010
Neue Ziele für die Photopharmakologie
2016 StandoutNobel
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation
2019 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
2005
Antibody−Dendrimer Conjugates: The Number, Not the Size of the Dendrimers, Determines the Immunoreactivity
2008
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Synthesis of a DOTA−Biotin Conjugate for Radionuclide Chelation via Cu-Free Click Chemistry
2010
Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists
2017 StandoutNobel
New manganese catalysts for alcohol oxidation
2002 StandoutNobel
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Theranostics: Combining Imaging and Therapy
2011
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
2015
Detection of Liver Metastases From Endocrine Tumors: A Prospective Comparison of Somatostatin Receptor Scintigraphy, Computed Tomography, and Magnetic Resonance Imaging
2004
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
2006
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Guidelines for the management of thyroid cancer
2014 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Polar Red‐Emitting Rhodamine Dyes with Reactive Groups: Synthesis, Photophysical Properties, and Two‐Color STED Nanoscopy Applications
2013 StandoutNobel
Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
2014
Works of A. Heppeler being referenced
Metal‐Ion‐Dependent Biological Properties of a Chelator‐Derived Somatostatin Analogue for Tumour Targeting
2008
Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides
2000
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy
1997
Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model
2002
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data
2001
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
2000
Synthesis, structure and characterisation of amido derivatives of [9]aneN3(1,4,7-triazacyclononane)
1996
Preclinical Comparison in AR4–2J Tumor-Bearing Mice of Four Radiolabeled 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Somatostatin Analogs for Tumor Diagnosis and Internal Radiotherapy*
2000
Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy
1999
Yttrium-90 DOTATOC: first clinical results
1999